Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Jul 29.
Published in final edited form as: Childs Nerv Syst. 2011 Oct 5;27(12):2183–2186. doi: 10.1007/s00381-011-1595-6

Genetic–environmental interaction in a unique case of Muenke syndrome with intracranial hypertension

Nneamaka B Agochukwu 1,2, Benjamin D Solomon 3, Anna Zajaczkowska-Kielska 4, Christopher J Lyons 5, Travis Pollock 5, Ash Singhal 6, Margot I Van Allen 7, Maximilian Muenke 8
PMCID: PMC4101181  NIHMSID: NIHMS611177  PMID: 21971908

Introduction

Craniosynostosis, the premature fusion of one of more of the cranial sutures, is relatively common, with an incidence of approximately 1 in 3,000 live births [3]. Although craniosynostosis typically occurs in an isolated manner, without accompanying anomalies, it is also a feature of more than 150 genetic syndromes, the most common of which is Muenke syndrome [4, 15, 19]. Of all patients with craniosynostosis, 8% are estimated to have Muenke syndrome; 24% of patients with craniosynostosis and a known genetic cause have Muenke syndrome [15, 19, 29]. Muenke syndrome is an autosomal dominant craniosynostosis syndrome due to the defining point mutation, c.749C>G, in the FGFR3 gene, resulting in p.Pro250Arg [1, 16]. The condition is characterized by coronal craniosynostosis (bilateral more often than unilateral), carpal and/or tarsal bone fusion, hearing loss, and developmental delay. Following surgical treatment of the craniosynostosis, individuals with Muenke syndrome are five times more likely than individuals with non-syndromic craniosynostosis to need transcranial reoperation for raised intracranial pressure [28].

Vitamin A, which is necessary for the synthesis of visual pigments and is an important component of membrane stability, is obtained from two sources: preformed vitamin A (derived from animal sources) and provitamin A (from carotenoids, fruits, and vegetables) [11, 12]. Preformed vitamin A is efficiently absorbed and used by humans at absorption rates of 70–90%. Provitamin A, derived from carotenoids and plant foods, is absorbed much less efficiently, at rates of 20–30% [12]. Vitamin A toxicity has traditionally been thought of as being unlikely to result from provitamin A due to its relatively poor absorption efficiency and the fact that the conversion of carotenoids to vitamin A is highly regulated. For this reason, carotenemia, a term used to describe excess levels of carotene (a source of provitamin A) in the blood, has been described as being benign aside from the yellow pigmentation of skin. There have been several reports of benign carotenemia secondary to carrot ingestion, the most common cause of carotenemia, as well as dietary dried seaweed, green beans, and nutrient supplementation [14, 17, 26, 27].

The association of vitamin A with intracranial hypertension is well established. In one study of idiopathic intracranial hypertension, affected patients had significant elevation of serum retinal (a derivative of vitamin A) compared to controls [13]. Vitamin A is also one of the known contributors to the pathophysiology of idiopathic intracranial hypertension, although its exact role has yet to be elucidated [8]. Hypervitaminosis A has also been associated with hydrocephalus, a known structural cause of increased intracranial pressure [22].

Case report

This patient participated in the IRB-approved National Human Genome Research Institute protocol on Muenke syndrome, with informed consent obtained.

The patient was a 3.5-year-old Caucasian male with bicoronal craniosynostosis secondary to Muenke syndrome (formally diagnosed with Muenke syndrome following genetic testing at the age of 20 months) who underwent bilateral fronto-orbital advancement and reconstruction at 9 months. Genetic testing revealed that his mutation was a de-novo mutation (not inherited from either of his parents). He had the following additional findings on further investigation, all consistent with the diagnosis of Muenke syndrome: bilateral sensorineural hearing loss, digital anomalies (broad toes and thumbs, brachydactyly), and mild developmental delay. At the age of 3.5 years, he presented with moderate papilledema and yellow skin discoloration. This yellow discoloration had been present for the prior 8 months but had increased over the past month. There was no yellow discoloration of his sclera (this finding is used to clinically distinguish hypercarotenemia from jaundice), nor did he have vomiting, abdominal pain, dark urine, or acholic stools. Dilated fundoscopy showed moderately swollen optic discs bilaterally. Neurological exam revealed no focal neurological deficits. He had no symptoms of increased intracranial pressure (ICP), with no headache, nausea, vomiting, irritability, change in appetite, or change in behavior. Head CT showed asymmetric lateral ventricles, with the left more effaced than the right, lack of well defined sulci, and cranial crowding (Figs. 1, 2 and 3). ICP monitoring showed an elevated ICP at 20–26 mmHg (normal 1–15 mmHg). Dietary history revealed high carotene intake from vegetables high in carotene (carrots and zucchini) and from intake of a commercial “fruit and veggie” juice, which has high carotene content. Serum carotene was elevated at 9.9 μmol/L (normal 1–4 μmol/L); serum vitamin A levels were not obtained. Due to the known association of vitamin A (of which carotene is a source) with increased ICP, it was advised that “fruit and veggie” juice intake be discontinued and that the amount of carotene-containing vegetables and fruits in his diet be reduced. Two months after the juice was discontinued, ophthalmology exam revealed normal vision and resolving papilledema. At this time, plans for reoperation were canceled, and he was determined to have no major need for surgery. However, approximately 2 months later, he presented with worsening papilledema, this time with bilateral sixth nerve palsies. He remained clinically asymptomatic, and his physical and neurological exam was otherwise stable and non-focal. He underwent re-operation at the age of 4 years. He is without a recurrence of the intracranial hypertension at 1.5-year follow-up.

Fig. 1.

Fig. 1

Computed tomography (CT scans) of the brain showing asymmetry of the lateral ventricles, with more effacement of the left ventricle (white arrow) compared to the right. Note the lack of well-defined sulci secondary to the effect of cranial crowding

Fig. 2.

Fig. 2

Cranial crowding on head CT, with cerebellar tonsils (black arrows) approaching the foramen magnum

Fig. 3.

Fig. 3

Head CT. Note the lack of well-defined sulci, due to the effect of cranial crowding and increased intracranial pressure

Discussion

Although there is strong evidence for the association of hypervitaminosis A and increased ICP, the precise mechanism is not well understood. It is often speculated that vitamin A affects the absorption of the cerebrospinal fluid via the arachnoid villus [8].

Likewise, the mechanism of increased ICP in patients with Muenke syndrome and other forms of syndromic craniosynostosis has yet to be elucidated. It is known, however, that FGFR3, the gene whose mutation causes Muenke syndrome—in addition to being expressed in the cartilage of developing bone, cranial sutures, and inner ear—is also diffusely expressed in the central nervous system [18]. It is likely that the increased intracranial pressure observed in patients with Muenke syndrome is due to a combination of differences in signaling, formation, and morphology of the skull, brain, dura, and cranial sutures.

Interestingly, most of the association between vitamin A and intracranial hypertension has been associated with preformed vitamin A, and not with the ingestion of carotene, which is thought to be benign even in excessive amounts. This case, along with a prior reported case of intracranial hypertension associated with carotene intake, challenges this assumption [9].

Donahue [9] reported a patient with idiopathic intracranial hypertension, which resolved after weight loss but recurred in association with a large, sustained dietary intake of fresh carrots. After cessation of carrot intake for 7 weeks, papilledema markedly decreased along with blood retinol levels. The author concluded from this study that carrot intake is a mechanism for idiopathic intracranial hypertension associated with hypervitaminosis A. Vitamin A levels were not obtained in our patient; however, he did have elevated carotene levels. The rapid increase in the yellow discoloration of his palms and soles at the same time period of his increased ICP suggests that not only did his dietary intake of carotene play a role in his increased ICP, but also that he likely had hypervitaminosis A, as it is from the conversion to vitamin A that excess carotene intake leads to intracranial hypertension.

While this report involves a hypothetical complex interplay between both genetic and environmental causes of intracranial hypertension, it is admittedly difficult to delineate the precise role each played in this case. Both vitamin A and Fibroblast Growth Factor Receptors (FGFRs) play roles in development, differentiation, bone formation, and inner ear development [7, 10, 24]. Regulation of local retinoid (a derivative of vitamin A) concentrations is essential to appropriate patterning and development of the inner ear [10]. In fact, retinoids, its nuclear receptors, and the enzymes required for retinoid synthesis are endogenous to the developing ear [2, 20, 21]. Fgfr3 has been shown in multiple animal models to be essential for normal inner ear development [5]. Further, Fibroblast Growth Factor (FGF) signaling is required for the normal induction, patterning, and morphogenesis of the inner ear epithelium [23, 25, 30]. Additionally, animal studies have shown that retinoid signaling is important for development of the brain, an organ where Fgfr3 is diffusely expressed during development [18, 31]. Vitamin A and FGFR3 are effectors of similar pathways and processes that likely intersect and interact at certain points along the different pathways.

Given this, the most plausible explanation is that there is synergism between these two entities. Corroborating evidence includes the fact that immediately after cessation of carotene intake, his papilledema and intracranial hypertension significantly improved to the point where plans for re-operation were canceled, and then later worsened. It is possible that this patient may have had a mild, sub-clinical increase in ICP that was un-masked by the excess carotene intake. This possibility is further supported by the fact that postoperative intracranial hypertension, while more common in Muenke syndrome than non-syndromic or non-genetic causes of craniosynostosis, is relatively rare compared to the other more severe craniosynostosis syndromes, such as Apert, Crouzon, and Pfeiffer syndromes [6].

These cases demonstrate the importance of placing a clinical picture in context; possibly, excess carotene intake is benign in individuals without pre-existing risks for intracranial hypertension, whereas in those individuals with pre-existing risk factors, excess carotene intake is more dangerous. This case suggests excess carotene intake as an environmental susceptibility factor for intracranial hypertension, particularly in at risk individuals.

Acknowledgements

We would like to express our gratitude to the patient described in this article and the patient's family for their willingness to participate in our study and for their informed consent to participate in our study and to publish this report. We also thank those who played a role in the care of this patient, including Dr. Douglas Courtemanche of the Division of Plastic Surgery, University of British Columbia. This research was supported by the Division of Intramural Research at the National Human Genome Research Institute (National Institutes of Health, Department of Health and Human Services, USA).

References

  • 1.Bellus GA, Gaudenz K, Zackai EH, Clarke LA, Szabo J, Francomano CA, Muenke M. Identical mutations in three different fibroblast growth factor receptor genes in autosomal dominant craniosynostosis syndromes. Nat Genet. 1996;14:174–176. doi: 10.1038/ng1096-174. [DOI] [PubMed] [Google Scholar]
  • 2.Biesalski HK, Weiser H. Sensitive analysis of retinyl esters by isocratic adsorption chromatography. J Clin Chem Clin Biochem. 1989;27:65–74. doi: 10.1515/cclm.1989.27.2.65. [DOI] [PubMed] [Google Scholar]
  • 3.Boulet SL, Rasmussen SA, Honein MA. A population-based study of craniosynostosis in metropolitan Atlanta, 1989–2003. Am J Med Genet A. 2008;146A:984–991. doi: 10.1002/ajmg.a.32208. [DOI] [PubMed] [Google Scholar]
  • 4.Cohen MM., Jr Craniosynostoses: phenotypic/molecular correlations. Am J Med Genet. 1996;61:98. [Google Scholar]
  • 5.Colvin JS, Bohne BA, Harding GW, McEwen DG, Ornitz DM. Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3. Nat Genet. 1996;12:390–397. doi: 10.1038/ng0496-390. [DOI] [PubMed] [Google Scholar]
  • 6.de Jong T, Bannink N, Bredero-Boelhouwer HH, van Veelen ML, Bartels MC, Hoeve LJ, Hoogeboom AJ, Wolvius EB, Lequin MH, van der Meulen JJ, van Adrichem LN, Vaandrager JM, Ongkosuwito EM, Joosten KF, Mathijssen IM. Long-term functional outcome in 167 patients with syndromic craniosynostosis: defining a syndrome-specific risk profile. J Plast Reconstr Aesthet Surg. 2010;63:1635–1641. doi: 10.1016/j.bjps.2009.10.029. [DOI] [PubMed] [Google Scholar]
  • 7.Deng C, Wynshaw-Boris A, Zhou F, Kuo A, Leder P. Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell. 1996;84:911–921. doi: 10.1016/s0092-8674(00)81069-7. [DOI] [PubMed] [Google Scholar]
  • 8.Digre K, Warner J. Is vitamin A implicated in the pathophysiology of increased intracranial pressure? Neurology. 2005;64:1827. [PubMed] [Google Scholar]
  • 9.Donahue SP. Recurrence of idiopathic intracranial hypertension after weight loss: the carrot craver. Am J Ophthalmol. 2000;130:850–851. doi: 10.1016/s0002-9394(00)00607-3. [DOI] [PubMed] [Google Scholar]
  • 10.Frenz DA, Liu W, Cvekl A, Xie Q, Wassef L, Quadro L, Niederreither K, Maconochie M, Shanske A. Retinoid signaling in inner ear development: a “Goldilocks” phenomenon. Am J Med Genet A. 2010;152A:2947–2961. doi: 10.1002/ajmg.a.33670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Friedman DI. Medication-induced intracranial hypertension in dermatology. Am J Clin Dermatol. 2005;6:29–37. doi: 10.2165/00128071-200506010-00004. [DOI] [PubMed] [Google Scholar]
  • 12.Gerster H. Vitamin A-functions, dietary requirements and safety in humans. Int J Vitam Nutr Res. 1997;67:71–90. [PubMed] [Google Scholar]
  • 13.Jacobson DM, Berg R, Wall M, Digre KB, Corbett JJ, Ellefson RD. Serum vitamin A concentration is elevated in idiopathic intracranial hypertension. Neurology. 1999;53:1114–1118. doi: 10.1212/wnl.53.5.1114. [DOI] [PubMed] [Google Scholar]
  • 14.Leung AK. Benign carotenemia in children. Can Fam Physician. 1989;35:81–83. [PMC free article] [PubMed] [Google Scholar]
  • 15.Moloney DM, Wall SA, Ashworth GJ, Oldridge M, Glass IA, Francomano CA, Muenke M, Wilkie AO. Prevalence of Pro250Arg mutation of fibroblast growth factor receptor 3 in coronal craniosynostosis. Lancet. 1997;349:1059–1062. doi: 10.1016/s0140-6736(96)09082-4. [DOI] [PubMed] [Google Scholar]
  • 16.Muenke M, Gripp KW, McDonald-McGinn DM, Gaudenz K, Whitaker LA, Bartlett SP, Markowitz RI, Robin NH, Nwokoro N, Mulvihill JJ, Losken HW, Mulliken JB, Guttmacher AE, Wilroy RS, Clarke LA, Hollway G, Ades LC, Haan EA, Mulley JC, Cohen MM, Bellus GA, Francomano CA, Moloney DM, Wall SA, Wilkie AO, Zackai EH. A unique point mutation in the fibroblast growth factor receptor 3 gene (FGFR3) defines a new craniosynostosis syndrome. Am J Hum Genet. 1997;60:555–564. [PMC free article] [PubMed] [Google Scholar]
  • 17.Nishimura Y, Ishii N, Sugita Y, Nakajima H. A case of carotenodermia caused by a diet of the dried seaweed called nori. J Dermatol. 1998;25:685–687. doi: 10.1111/j.1346-8138.1998.tb02482.x. [DOI] [PubMed] [Google Scholar]
  • 18.Peters K, Ornitz D, Werner S, Williams L. Unique expression pattern of the FGF receptor 3 gene during mouse organogenesis. Dev Biol. 1993;155:423–430. doi: 10.1006/dbio.1993.1040. [DOI] [PubMed] [Google Scholar]
  • 19.Rannan-Eliya SV, Taylor IB, De Heer IM, Van Den Ouweland AM, Wall SA, Wilkie AO. Paternal origin of FGFR3 mutations in Muenke-type craniosynostosis. Hum Genet. 2004;115:200–207. doi: 10.1007/s00439-004-1151-5. [DOI] [PubMed] [Google Scholar]
  • 20.Romand R, Hashino E, Dollé P, Vonesch JL, Chambon P, Ghyselinck NB. The retinoic acid receptors RARalpha and RARgamma are required for inner ear development. Mech Dev. 2002;119:213–223. doi: 10.1016/s0925-4773(02)00385-4. [DOI] [PubMed] [Google Scholar]
  • 21.Romand R, Dollé P, Hashino E. Retinoid signaling in inner ear development. J Neurobiol. 2006;66:687–704. doi: 10.1002/neu.20244. [DOI] [PubMed] [Google Scholar]
  • 22.Saltzman MD, King EC. Central physeal arrests as a manifestation of hypervitaminosis A. J Pediatr Orthop. 2007;27:351–353. doi: 10.1097/BPO.0b013e3180340a06. [DOI] [PubMed] [Google Scholar]
  • 23.Schimmang T. Expression and functions of FGF ligands during early otic development. Int J Dev Biol. 2007;51:473–481. doi: 10.1387/ijdb.072334ts. [DOI] [PubMed] [Google Scholar]
  • 24.Sheng N, Xie Z, Wang C, Bai G, Zhang K, Zhu Q, Song J, Guillemot F, Chen YG, Lin A, Jing N. Retinoic acid regulates bone morphogenic protein signal duration by promoting the degradation of phosphorylated Smad1. Proc Natl Acad Sci USA. 2010;107:18886–18891. doi: 10.1073/pnas.1009244107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Shim K. The auditory sensory epithelium: the instrument of sound perception. Int J Biochem Cell Biol. 2006;38:1827–1833. doi: 10.1016/j.biocel.2006.03.012. [DOI] [PubMed] [Google Scholar]
  • 26.Takita Y, Ichimiya M, Hamamoto Y, Muto M. A case of carotenemia associated with ingestion of nutrient supplements. J Dermatol. 2006;33:132–134. doi: 10.1111/j.1346-8138.2006.00028.x. [DOI] [PubMed] [Google Scholar]
  • 27.Tanya AS, Erik S. Carotenemia associated with green bean ingestion. Pediat Dermatol. 2004;21:657–659. doi: 10.1111/j.0736-8046.2004.21609.x. [DOI] [PubMed] [Google Scholar]
  • 28.Thomas GP, Wilkie AO, Richards PG, Wall SA. FGFR3 P250R mutation increases the risk of reoperation in apparent `nonsyndromic' coronal craniosynostosis. J Craniofac Surg. 2005;16:347–352. doi: 10.1097/01.scs.0000157024.56055.f2. [DOI] [PubMed] [Google Scholar]
  • 29.Wilkie AO, Byren JC, Hurst JA, Jayamohan J, Johnson D, Knight SJ, Lester T, Richards PG, Twigg SR, Wall SA. Prevalence and complications of single gene and chromosomal disorders in craniosynostosis. Pediatrics. 2010;126:e391–e400. doi: 10.1542/peds.2009-3491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Wright TJ, Mansour SL. FGF signaling in ear development and innervation. Curr Top Dev Biol. 2003;57:225–259. doi: 10.1016/s0070-2153(03)57008-9. [DOI] [PubMed] [Google Scholar]
  • 31.Zhang W, Deng ZL, Chen L, Zuo GW, Luo Q, Shi Q, Zhang BQ, Wagner ER, Rastegar F, Kim SH, Jiang W, Shen J, Huang E, Gao Y, Gao JL, Zhou JZ, Luo J, Huang J, Luo X, Bi Y, Su Y, Yang K, Liu H, Luu HH, Haydon RC, He TC, He BC. Retinoic acids potentiate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One. 2010;5:e11917. doi: 10.1371/journal.pone.0011917. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES